You are here

Start of R&D tests in Canada

Two new patents in Japan

Lyon, 27 July 2016 - Amoéba announced today that it has obtained two new patents in Japan and one in Europe, all three contributing to its objective to develop new applications for its biological biocide. The first patent, issued in Japan by the Japanese Patents Office, confirms that AMOEBA’s solution has biocidal action against the pathogenic bacteria Pseudomonas, primary germ implicated in nosocomial infections acquired in health-care institutions.

Update to MA schedule

Lyon, 8 June 2016 - Amoéba today announced a revised schedule for its acquisition of provisional MA. The assessment report required to obtain the provisional MA for France and Europe, initially scheduled to be delivered in May 2016, should be available during the second half of 2016.

Emmanuel Macron meets Amoéba

This Thursday, 2nd June 2016, the minister for Economy, Emmanuel Macron, attended two scheduled meetings in Lyon: a meeting of the strategic committee for the “Chemistry and materials” sector and a meeting with “creative and economic innovators”. Fabrice Plasson, President of Amoéba, was invited to this meeting at the Town Hall, organised by the senator-lord mayor Gérard Collomb.

New fundraising campaign for Amoéba

Lyon, May 13, 2016 - Amoéba announced an increase in capital thanks to the private placement of new shares for a total of around EUR 14.7 million. This new fundraising campaign was open to European and American investors despite the current difficult economic context.

Europe: 3 countries open to tests

Chassieu, 26 April 2016 - After having obtained market approval for research and development purposes in France in 2014 and in Canada in 2015, today Amoéba obtained market approval for R&D purposes for Belgium and Italy, and an extension to its approval in the Netherlands.

Amoéba associates itself with World Water Day

Water covers 71% of the Earth’s surface, it is necessary for all living organisms, both animal and vegetable, and is also widely used in industrial processes, which have become unavoidable today. Water is an essential resource; we should take care of it.

Placing on the market planned in Turkey

Chassieu, Kocaeli - Turkey - 10 March 2016 - AMOEBA (FR0011051598 - AMEBA) producer of a biological biocide capable of eliminating bacterial risk in water, announced today that it has signed a letter of intent prior to entering into a definitive agreement on the distribution of its product in Turkey by GREEN Chemicals for a 3-year period.

Provisional MA schedule

Chassieu, 29 February 2016 - AMOEBA announces that it will submit a request for provisional MA for all of Europe as soon as the active principle in its biological biocide has been validated by the regulatory authority ANSES (French Agency for Food, Environmental and Occupational Health & Safety).

Two more patents for Amoéba

Chassieu, 25 February 2016 - AMOEBA has just been granted two new patents which will allow it to develop new applications for its biological biocide. The first patent, granted for the European market, claims a biocidal action for AMOEBA’s solution against the pathogenic bacteria Pseudomonas, primary agent responsible for nosocomial infections in healthcare institutions; it applies to the Domestic Hot Water (DHW) sector.